Allurion Technologies (ALURD) Asset Utilization Ratio (2023 - 2026)

Allurion Technologies (ALURD) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	186.78 Bn	179.48 Bn	6.27 Bn	0.46
2	Stryker	131.95 Bn	129.07 Bn	3.81 Bn	0.54
3	Medtronic	111.27 Bn	102.05 Bn	6.41 Bn	0.39
4	Boston Scientific	68.58 Bn	67.13 Bn	3.61 Bn	0.47
5	Edwards Lifesciences	48.31 Bn	44.63 Bn	1.29 Bn	0.47
6	GE HealthCare Technologies	29.23 Bn	26.94 Bn	1.98 Bn	0.57
7	Dexcom	28.90 Bn	27.78 Bn	750.30 Mn	0.74
8	Smith & Nephew	28.19 Bn	27.62 Bn	-	-
9	Koninklijke Philips	24.33 Bn	21.29 Bn	2.01 Bn	0.65
10	Allurion Technologies	60.75 Mn	55.69 Mn	1.23 Mn	0.85

Download Data